Jeanelle Ariza1, Hailee Rogers1, Anna Hartvigsen1, Melissa Snell1, Michael Dill1, Derek Judd1, Paul Hagerman2,3, Verónica Martínez-Cerdeño1,2. 1. Department of Pathology and Laboratory Medicine, UC Davis School of Medicine, and the Institute for Pediatric Regenerative Medicine and Shriners Hospitals for Children of Northern California, Sacramento, California. 2. MIND Institute, UC Davis Medical Center, Sacramento, California. 3. Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, Sacramento, California.
Abstract
BACKGROUND: Fragile X-associated tremor/ataxia syndrome is an adult-onset disorder associated with premutation alleles of the FMR1 gene. This disorder is characterized by progressive action tremor, gait ataxia, and cognitive decline. Fragile X-associated tremor/ataxia syndrome pathology includes dystrophic white matter and intranuclear inclusions in neurons and astrocytes. We previously demonstrated that the transport of iron into the brain is altered in fragile X-associated tremor/ataxia syndrome; therefore, we also expect an alteration of iron metabolism in brain areas related to motor control. Iron is essential for cell metabolism, but uncomplexed iron leads to oxidative stress and contributes to the development of neurodegenerative diseases. We investigated a potential iron modification in the putamen - a structure that participates in motor learning and performance - in fragile X-associated tremor/ataxia syndrome. METHODS: We used samples of putamen obtained from 9 fragile X-associated tremor/ataxia syndrome and 9 control cases to study iron localization using Perl's method, and iron-binding proteins using immunostaining. RESULTS: We found increased iron deposition in neuronal and glial cells in the putamen in fragile X-associated tremor/ataxia syndrome. We also found a generalized decrease in the amount of the iron-binding proteins transferrin and ceruloplasmin, and decreased number of neurons and glial cells that contained ceruloplasmin. However, we found increased levels of iron, transferrin, and ceruloplasmin in microglial cells, indicating an attempt by the immune system to remove the excess iron. CONCLUSIONS: Overall, found a deficit in proteins that eliminate extra iron from the cells with a concomitant increase in the deposit of cellular iron in the putamen in Fragile X-associated tremor/ataxia syndrome.
BACKGROUND:Fragile X-associated tremor/ataxia syndrome is an adult-onset disorder associated with premutation alleles of the FMR1 gene. This disorder is characterized by progressive action tremor, gait ataxia, and cognitive decline. Fragile X-associated tremor/ataxia syndrome pathology includes dystrophic white matter and intranuclear inclusions in neurons and astrocytes. We previously demonstrated that the transport of iron into the brain is altered in fragile X-associated tremor/ataxia syndrome; therefore, we also expect an alteration of iron metabolism in brain areas related to motor control. Iron is essential for cell metabolism, but uncomplexed iron leads to oxidative stress and contributes to the development of neurodegenerative diseases. We investigated a potential iron modification in the putamen - a structure that participates in motor learning and performance - in fragile X-associated tremor/ataxia syndrome. METHODS: We used samples of putamen obtained from 9 fragile X-associated tremor/ataxia syndrome and 9 control cases to study iron localization using Perl's method, and iron-binding proteins using immunostaining. RESULTS: We found increased iron deposition in neuronal and glial cells in the putamen in fragile X-associated tremor/ataxia syndrome. We also found a generalized decrease in the amount of the iron-binding proteins transferrin and ceruloplasmin, and decreased number of neurons and glial cells that contained ceruloplasmin. However, we found increased levels of iron, transferrin, and ceruloplasmin in microglial cells, indicating an attempt by the immune system to remove the excess iron. CONCLUSIONS: Overall, found a deficit in proteins that eliminate extra iron from the cells with a concomitant increase in the deposit of cellular iron in the putamen in Fragile X-associated tremor/ataxia syndrome.
Authors: J R Brouwer; E J Mientjes; C E Bakker; I M Nieuwenhuizen; L A Severijnen; H C Van der Linde; D L Nelson; B A Oostra; R Willemsen Journal: Exp Cell Res Date: 2006-10-13 Impact factor: 3.905
Authors: Sarah M Coffey; Kylee Cook; Nicole Tartaglia; Flora Tassone; Danh V Nguyen; Ruiqin Pan; Hannah E Bronsky; Jennifer Yuhas; Mariya Borodyanskaya; Jim Grigsby; Melanie Doerflinger; Paul J Hagerman; Randi J Hagerman Journal: Am J Med Genet A Date: 2008-04-15 Impact factor: 2.802
Authors: Cary S Kogan; Jeremy Turk; Randi J Hagerman; Kim M Cornish Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2008-09-05 Impact factor: 3.568
Authors: Claudia M Greco; Flora Tassone; Dolores Garcia-Arocena; Nicole Tartaglia; Sarah M Coffey; Timothy K Vartanian; James A Brunberg; Paul J Hagerman; Randi J Hagerman Journal: Arch Neurol Date: 2008-08
Authors: Jun Yi Wang; David Hessl; Andrea Schneider; Flora Tassone; Randi J Hagerman; Susan M Rivera Journal: JAMA Neurol Date: 2013-08 Impact factor: 18.302
Authors: Carmen Falcone; Marisol Wolf-Ochoa; Sarwat Amina; Tiffany Hong; Gelareh Vakilzadeh; William D Hopkins; Patrick R Hof; Chet C Sherwood; Paul R Manger; Stephen C Noctor; Verónica Martínez-Cerdeño Journal: J Comp Neurol Date: 2019-01-25 Impact factor: 3.215
Authors: Jun Yi Wang; David Hessl; Flora Tassone; Kyoungmi Kim; Randi J Hagerman; Susan M Rivera Journal: Neurobiol Aging Date: 2019-09-24 Impact factor: 4.673
Authors: Walker S McKinney; Zheng Wang; Shannon Kelly; Pravin Khemani; Su Lui; Stormi P White; Matthew W Mosconi Journal: Front Integr Neurosci Date: 2019-10-02
Authors: Maria Jimena Salcedo-Arellano; Ana Maria Cabal-Herrera; Nattaporn Tassanakijpanich; Yingratana A McLennan; Randi J Hagerman Journal: Biomedicines Date: 2020-05-25
Authors: Jessica L Famula; Forrest McKenzie; Yingratana A McLennan; James Grigsby; Flora Tassone; David Hessl; Susan M Rivera; Veronica Martinez-Cerdeno; Randi J Hagerman Journal: Front Neurol Date: 2018-08-22 Impact factor: 4.003